Phenotypic Detection of Extended Spectrum β-Lactamase and AmpC producing Enterobacteriaceae Isolated in A General Hospital
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2018, Vol 8, Issue 3
Abstract
Phenotypic Detection of Extended Spectrum β-Lactamase and AmpC producing Enterobacteriaceae Isolated in A General Hospital Cecile Okalla Ebongue1,2, Roane Nkodo Mengue2, Jean-Pierre Nda Mefo’o1,2, Elvis Temfack1, Emmanuel Roddy Mengue1, Dieudonne Adiogo2 1Laboratory of Clinical Biology, General Hospital, Douala, Cameroon 2Department of Biological Sciences, Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Cameroon ABSTRACT Objective: The antibiotic resistance of Enterobacteriaceae is a worldwide preoccupation, and misuse antibiotics of beta-lactam group allowed the development of bacteria producing extended spectrum beta-lactamase and cephalosporinase AmpC enzymes type resistance. The aim of this study was to determine the frequency of these enzymes among strains isolated at the General Hospital in Douala, Cameroon. Methods: We conducted a cross-sectional study. For phenotypic detection of resistance enzymes, MASTDISCS™ test impregnated third and fourth generation cephalosporin’s was used by diffusion on Mueller Hinton agar. Measuring the inhibition areas and comparing the inhibition diameters determined the nature of the resistance mechanism. Results: This study included 195 strains of Enterobacteriaceae. The most frequent species were Escherichia coli and Klebsiella pneumoniae, with a frequency of 49.2% and 31.3% respectively. After determination of resistance phenotypes, 101 (51.8%) isolates were found to be producing resistance enzymes. The frequency of ESBL-producing Enterobacteriaceae was 19.5%; AmpC producing was 14.3% and both enzymes (AmpC + ESBL) 17.9%. E. coli and K. pneumoniae resistance rates were 90% and 83.7% for Cotrimoxazole, 82.5% and 78.3% for ciprofloxacin, 20% and 13.5% for Amikacin, respectively. Imipenem, Amikacin and Fosfomycin were the most active molecules with 4.9%, 19.8% and 33.6%, out of 101 resistant strains, respectively. Conclusion: This study showed a high frequency of resistance enzyme producing strains. This situation leads to resistance to antibiotics most commonly used. This finding justifies a change in prescription habits for protection of molecules that are still active. J Microbiol Infect Dis 2018; 8(3):113-119
Authors and Affiliations
Cecile Okalla Ebongue, Roane Nkodo Mengue, Jean-Pierre Nda Mefo’o, Elvis Temfack, Emmanuel Roddy Mengue, Dieudonne Adiogo
Ethionamide depolama sıcaklığının duyarlılık testine etkisi
Amaç: Ethionamide ısıya duyarlı yapısı nedeniyle, ilaç duyarlılık testinde (DST) ısının etkisini ve sıvı veya katı ortamdaki dayanıklılık durumunun araştırılması amaçlanmıştır. Yöntemler: Ethionamide çalışma solüsyonu v...
Comparison of microscopy and PCR in detection of Mycobacterium tuberculosis
Objective: Tuberculosis (TB) one of the most important major causes of mortality and morbidity around the world. Early detection of TB affords to prevent transmission of TB and better treatment options. The aim of this...
Efficacy of Histochemical Staining Techniques in the Detection of Plasmodium falciparum Histidine-Rich Proteins in Blood of Children with Malaria
Efficacy of Histochemical Staining Techniques in the Detection of Plasmodium falciparum Histidine-Rich Proteins in Blood of Children with Malaria Mfoniso Udonkang1, Mokutima Eluwa2, Paul Inyang-Etoh3, Imeobong Inyang1, A...
Orta Doğu Solunum Sendromu: MERS
Orta Doğu Solunum Sendromu: MERSOrta Doğu Solunum Sendromu coronovirüsü (MERS-CoV) yeni ortaya çıkan bir solunum virüsüdür. Bu virus ilk olarak 2012 yılında Suudi Arabistan’da tanımlanmıştır. Orta Doğu solunum sendromu k...
Streptococcus constellatus Causing Mycotic Aneurysm in A Patient with Diffuse Large B-Cell Lymphoma
This is a first case of mycotic aneurysm due to Streptococcus constellatus in a 58 years old male patient with diffuse large B cell lymphoma. A mycotic aneurysm is a rare but life threatening and potentially fatal sequel...